A scoping review of the pharmacovigilance systems in west African region

Jalloh, I; James, PB; Abiri, OT; Wiafe, E; Mensah, K; Padayachee, N

A scoping review of the pharmacovigilance systems in west African region

Jalloh, I James, PB Abiri, OT Wiafe, E Mensah, K Padayachee, N

Permalink

Publisher:: Christian Journal for Global Health
Publication Type:: Journal Article
Citation:: Christian Journal for Global Health, 2025, 12, (2), pp. 1-27
Issue Date:: 2025-01-01

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (834.46 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Jalloh, I
dc.contributor.author	James, PB
dc.contributor.author	Abiri, OT
dc.contributor.author	Wiafe, E
dc.contributor.author	Mensah, K
dc.contributor.author	Padayachee, N
dc.date.accessioned	2026-04-24T06:43:37Z
dc.date.available	2026-04-24T06:43:37Z
dc.date.issued	2025-01-01
dc.identifier.citation	Christian Journal for Global Health, 2025, 12, (2), pp. 1-27
dc.identifier.issn	2167-2415
dc.identifier.issn	2167-2415
dc.identifier.uri	http://hdl.handle.net/10453/194810
dc.description.abstract	Background: Pharmacovigilance is essential for monitoring drug safety and managing adverse drug reactions, particularly In the context of Increasing médication use In West Africa. This review alms to assess the existing state of pharmacovigilance systems, regulatory frameworks, and adverse drug reaction reporting practices across the West African region. Methods: A systematic scoping review was performed in accordance with the methodology set out by the Joanna Briggs Institute, adhering to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. Literature searches conducted across seven databases resulted In 3,000 documents, of which 59 studies met the Inclusion criteria. The Included studies originated from six countries: Ghana, Nigeria, Burkina Faso, Côte d’Ivoire, Sierra Leone, and Senegal. Key themes identified In the review encompass pharmacovigilance systems, related policies, collaboration among stakeholders, and the challenges associated with reporting adverse drug reactions. Results: While all West African countries have established national pharmacovigilance centers and WHO Collaborating Center membership, gaps persist in legislation, enforcement, and public awareness. Challenges include inadequate resources, limited healthcare professional training, and communication barriers. Recommendations emphasize education, stakeholder engagement, and public awareness to improve adverse drug reaction reporting. Conclusion: Strengthening pharmacovigilance in West Africa requires a multipronged approach prioritizing policy, collaboration, and education to ensure drug safety and public health.
dc.language	en
dc.publisher	Christian Journal for Global Health
dc.relation.ispartof	Christian Journal for Global Health
dc.relation.isbasedon	10.15566/cjgh.v12i2.419
dc.rights	info:eu-repo/semantics/openAccess
dc.subject.classification	4206 Public health
dc.title	A scoping review of the pharmacovigilance systems in west African region
dc.type	Journal Article
utslib.citation.volume	12
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
utslib.copyright.status	open_access	*
dc.rights.license	This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
dc.date.updated	2026-04-24T06:43:35Z
pubs.issue	2
pubs.publication-status	Published
pubs.volume	12
utslib.citation.issue	2

Abstract:

Background: Pharmacovigilance is essential for monitoring drug safety and managing adverse drug reactions, particularly In the context of Increasing médication use In West Africa. This review alms to assess the existing state of pharmacovigilance systems, regulatory frameworks, and adverse drug reaction reporting practices across the West African region. Methods: A systematic scoping review was performed in accordance with the methodology set out by the Joanna Briggs Institute, adhering to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. Literature searches conducted across seven databases resulted In 3,000 documents, of which 59 studies met the Inclusion criteria. The Included studies originated from six countries: Ghana, Nigeria, Burkina Faso, Côte d’Ivoire, Sierra Leone, and Senegal. Key themes identified In the review encompass pharmacovigilance systems, related policies, collaboration among stakeholders, and the challenges associated with reporting adverse drug reactions. Results: While all West African countries have established national pharmacovigilance centers and WHO Collaborating Center membership, gaps persist in legislation, enforcement, and public awareness. Challenges include inadequate resources, limited healthcare professional training, and communication barriers. Recommendations emphasize education, stakeholder engagement, and public awareness to improve adverse drug reaction reporting. Conclusion: Strengthening pharmacovigilance in West Africa requires a multipronged approach prioritizing policy, collaboration, and education to ensure drug safety and public health.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/194810